AS

Aadarsh Sinha

Active Director Director DIN 10218105
DIN 10218105 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Aadarsh Sinha

Data last updated:

Aadarsh Sinha is a Director at Asuav Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10218105
Primary Designation Director
Industry Pharma
First Appointment 28 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jun 20232023Active

Board colleagues of Aadarsh Sinha

NameDINCompanyDesignation
Puspa Devi10218106Asuav Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Asuav Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Aadarsh Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aadarsh Sinha

Aadarsh Sinha currently holds 1 directorship: Asuav Pharmaceuticals Private Limited (Director, since 28 Jun 2023).

Aadarsh Sinha was first appointed on 28 Jun 2023 as Director at Asuav Pharmaceuticals Private Limited.

The current boards of Aadarsh Sinha's companies include Puspa Devi (Asuav Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available